Navigation Links
GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
Date:9/12/2007

tured and tested under GMP/GLP - EMEA (EU) and FDA

guidelines

-- Satisfactorily completed early Phase 1 human clinical trials for a DNA

HIV/AIDS vaccine

-- Are currently in 4 ongoing human trials started in 2006 with positive

immune responses reported in the majority of vaccine recipients as well

as good vaccine safety

-- Are in planning stage for a larger Phase 2 trial tentatively scheduled

for 2008

For further information, contact Donald Hildebrand or Jennifer Nelms at (404) 727-0971 or visit http://www.geovax.com.

Safe Harbor Statement: All statements in this news release, not statements of historical fact, are forward-looking statements. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, but are not limited to, whether; GeoVax can develop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be determined to be safe for use in humans, GeoVax's vaccines will be effective in preventing AIDS in humans, the vaccines will receive the regulatory approvals necessary to be licensed and marketed, GeoVax can raise the required capital to complete development of its vaccines, there is development of competitive products that may be more effective or easier to use than GeoVax's products, and other factors over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. Certain matters discussed in this news release are forward looking statements involving certain risks and uncertainties including, without limitations, risks detailed in the Companies Securities and Exchange Commission filings a
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
3. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
4. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
5. Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial Data
6. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
7. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
8. BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference
9. Sosei Announces Successful Completion of AD 923 Pharmacokinetic Study in the USA
10. Pegasys Study Authors Conclude that Patients Successfully Treated for Hepatitis C Can be Considered Cured
11. SkyePharma and Sciele Pharma Announce Successful Completion of New Sular Formulation Clinical Trial Programme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that ... in its catalogue: Personal Accident ... and Opportunities to 2017 ... The report provides in depth market analysis, ... accident and health insurance segment, including: • ...
(Date:8/20/2014)... , Aug. 20, 2014 The National Necrotizing ... Fernando Davila has been successfully treated for a life ... Dr, Anibal R. Gauto , Medical Director of Inpatient ... Eisenhower Medical Center in Rancho Mirage, California ... pioneered by Dr. John Crew at Seton Hospital ...
(Date:8/20/2014)... 20, 2014   Ventana Medical Systems, Inc. ... announced that its VENTANA System for Primary Diagnosis ... European Union for routine pathology, including primary diagnosis ... VENTANA Virtuoso software coupled with either the VENTANA ... scanner, provides automated digital slide creation, case management ...
Breaking Medicine Technology:Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 2Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 3Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 4Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 5Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 6Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 7Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 8Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 9Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 10Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 11Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 12Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 13Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 14Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 15Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 16Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 17Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 18Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 19Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 20Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 21Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 22Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 23Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 3Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 4Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 5Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 6Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3
... Md., July 26, 2011 Vapotherm announced today ... device developed specifically for homecare and other low ... the U.S. and European markets. ... patients in home and other extended care environments. ...
... July 26, 2011 Patients at Resurrection Medical Center (RMC), ... now receive non-invasive, whole-body PET/CT scans in just minutes. The ... in the world, the new 128-slice PET/CT scanner is a ... imaging techniques within a single machine. The ...
Cached Medicine Technology:Vapotherm Announces Commercial Launch of Flowrest® Homecare Device 2Resurrection Medical Center First in Chicago - 8th in the World - to Offer 128-Slice PET/CT Scanner Technology 2
(Date:8/20/2014)... August 20, 2014 With 3943.8% growth, Connexion ... of the nation’s fastest growing companies. The Inc. 500 ranks ... care sector. Connexion Point is the #1 fastest growing company ... Medicare and Medicaid, and its clients include four of the ... employs 1,000 people and has offices and contact centers in ...
(Date:8/20/2014)... a novel approach to treating cancer - using Botox. ... Science Translational Medicine shows that cancer growth ... nerves that are linked to cancer stem cells. The ... made the treatment cheap, safe and efficient. The researchers ... will soon start testing on humans. , The nervous ...
(Date:8/20/2014)... of endophthalmitis, a potentially blinding condition that can occur ... the well-known staphylococci ("staph") and streptococci ... in the August issue of Ophthalmology and ... at New York Eye and Ear Infirmary of Mount ... gram-positive bacteria, which include staph and strep infections, accounted ...
(Date:8/20/2014)... A common approach to treating kidney ... not improve survival chances for people who suddenly developed ... the University of Pittsburgh School of Medicine. ... journal PLOS One , suggest acute hemodialysis, an ... sudden kidney failure, may not provide a definitive benefit ...
(Date:8/20/2014)... UK (PRWEB) August 20, 2014 The ... to increase considerably in the offing across the top ... as of 2013 to around USD 8 billion by ... period. The growth is projected to be driven by ... which is currently lacking efficient treatment, unlike the non-squamous ...
Breaking Medicine News(10 mins):Health News:With 3943.8% Growth, Connexion Point, a Leader in Contact Centers for Health Care, Ranks 86th on the Inc. 500 List as One of the Nation’s Fastest Growing Companies 2Health News:Treating gastric cancer -- with Botox 2Health News:Researchers pinpoint most common causes of dangerous eye infection post surgery and trauma 2Health News:Researchers pinpoint most common causes of dangerous eye infection post surgery and trauma 3Health News:Pitt Analysis Questions Use of Acute Hemodialysis Treatment 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 3Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 4
... kill cervical cancer cells missed by chemotherapy , , TUESDAY, ... Avastin to radiation and chemotherapy improves results for patients ... mifepristone (RU-486, the so-called abortion pill) to chemotherapy kills ... are the conclusions of two reports on new trends ...
... OrthoSynetics(TM), the largest,provider of business services to orthodontic ... by hiring four new team members with,extensive experience ... year, we have bolstered our leadership team and,infrastructure ... said Chris Roussos, president and CEO of OrthoSynetics. ...
... Primary Less Than One Week Away, AARP Members,Gather ... They Debate,In Philadelphia., PHILADELPHIA, April 15 ... primary vote, the nation will be,watching Sen. Barack ... for,the Democratic Party,s presidential nomination during a debate ...
... Va., April 15 The American,Chemistry Council (ACC) ... Toxicology Program,s (NTP) Center for the Evaluation of,Risks ... last year,yesterday,s release of the draft NTP Brief ... or high level concerns for adverse effects of,bisphenol ...
... colon cancer, premature aging poses worries for manned missions ... -- Astronauts may be at increased risk of colon ... in space, a new report says. , The study, ... for Cancer Research annual meeting in San Diego, has ...
... tumors may be a factor, experts suggest, , , TUESDAY, ... of breast cancer dropped dramatically after millions of American ... doesn,t seem to have benefited black women. ... stayed essentially the same for black women from 2002 ...
Cached Medicine News:Health News:Extra Drug Improves Rectal Cancer Treatment 2Health News:Extra Drug Improves Rectal Cancer Treatment 3Health News:OrthoSynetics(TM) Expands Sales Team; Prepares to Grow 2Health News:AARP to Host Discussion and Debate Watch Event 2Health News:AARP to Host Discussion and Debate Watch Event 3Health News:Draft National Toxicology Program Report Supports Safety of Bisphenol A 2Health News: Space Radiation a Risk for Astronauts 2Health News:Breast Cancer Unchanged in Black Women, Despite Drop in HRT Use 2Health News:Breast Cancer Unchanged in Black Women, Despite Drop in HRT Use 3
... drying system, 220-240 V, includes Model 583 gel ... 583 gel dryer is a vacuum-based gel dryer ... cm with variable temperature control and three preprogrammed ... vacuum pump used for pulling vacuum on gel ...
... system utilizes a hot air drying device for ... to four drying frames at once. Gels are ... viewing. The assembly table is recessed to provide ... frame. This 230 V, 50 Hz system includes ...
The GelAir™ dryer is a component of the GelAir drying system. Supplied as a 115 V, 60 Hz gel drying oven....
... voltage power supply, the 105 is very simple ... switch control the output, which is variable in ... two-position switch toggles the bright LED display from ... is equipped with an over current detector for ...
Medicine Products: